The legacy of Viagra, and its creator copyright, presents a challenging case study for investors. At first a blockbuster drug, generating billions in income, its exclusivity period created a deluge of generic competition , significantly eroding its dominance. While certain firms may seek to capitalize on similar conditions , the existing landscape